期刊名称：DRUG AND ALCOHOL DEPENDENCE
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
Drug and Alcohol Dependence is an international journal devoted to publishing original research, scholarly reviews, commentaries, and policy analyses in the area of drug, alcohol and tobacco use and dependence. Articles range from studies of the chemistry of substances of abuse, their actions at molecular and cellular sites, in vitro and in vivo investigations of their biochemical, pharmacological and behavioural actions, laboratory-based and clinical research in humans, substance abuse treatment and prevention research, and studies employing methods from epidemiology, sociology, and economics. The rationale for this extensive coverage is the conviction that drug, alcohol and tobacco use/dependence cannot be understood in their entirety from a single perspective and that without an understanding of other areas of research, studies by individual investigators may be limited. The goal of the journal is to provide researchers, clinicians, and policy makers access to material from all perspectives in a single journal in a format that is understandable and which has received rigorous editorial review. The hope of its editors is to promote mutual understanding of the many facets of drug abuse to the benefit of all investigators involved in drug and alcohol research, and to facilitate the transfer of scientific findings to successful treatment and prevention practices.
The accepted abbreviation for Drug and Alcohol Dependence for bibliographic citation is Drug Alcohol Depend.
Drug and Alcohol Dependence is currently being distributed to all the members of the College on Problems on Drug Dependence (CPDD), the oldest scientific organization in the United States concerned with research on problems of drug dependence. Members of the CPDD are provided with both the print version as well as access to the full text of the current issue and back issues dating back to Vol. 46, Issue no. 1 of the online version as a benefit of membership.
Instructions to Authors
Authors who wish to submit manuscripts for publication in Drug and Alcohol Dependence are to adhere to the Instructions to Authors. Detailed guidance on manuscript preparation and submission is provided within the Instructions to Authors.
Authors also will be held responsible for and must observe the tenets of two documents: The Farmington Consensus. How these tenets relate to authors' contributions is explained in the Instructions to Authors.
As a service to authors, the required guides and documents described above are available for review and use through the following mechanisms:
- Instructions to Authors (PDF). Also published in each issue of Drug and Alcohol Dependence.
- Instructions to authors:Authors from North, South and Central America are invited to submit manuscripts to Robert L. Balster, Ph.D., Editor-in-Chief, Drug and Alcohol Dependence, Virginia Commonwealth University, Institute for Drug and Alcohol Studies, Room 760 Blackwell Smith Building, 410 N 12th Street, PO Box 980310, Richmond VA 23298-0310, USA. Authors from countries other than the Americas are invited to submit manuscripts to Ian Stolerman, Ph.D., Co-Editor, Drug and Alcohol Dependence, Institute of Psychiatry, De Crespigny Park, Denmark Hill, London SE5 8AF, UK. All Research Reports and Short Communications must be submitted with a statement signed by all authors that this represents an original research report and that all applicable subject protection guidelines and regulations were followed in the conduct of the research (see below). Page charges will not be requested.
Manuscripts, in quadruplicate, should be submitted double-spaced, should be in English, and should conform to formatting instructions for this journal as described below. Please consult a recent issue of the journal for examples of journal style. The manuscript should contain (i) a title page which includes addresses for all of the authors as they should appear in the publication and full contact information for the corresponding author (address, phone, FAX and E-mail) and (ii) an abstract page with a 200-word summary suitable for inclusion in electronic databases and search services and 3-6 key words for indexing. Abstracts can be either unstructured or structured with specific sections describing the background, methods, results and conclusions. (iii) The body of research reports will generally include introduction, methods, results and discussion sections. Further subheadings are acceptable. Review papers should also use section headings and subheadings. Sections should be numbered using the 1., 1.1, 1.1.1 etc. system. Extensive use of footnoting is not encouraged. (iv) An Acknowledgments page must declare all sources of financial support (direct or indirect) for any part of the work presented. If there was no support from external sponsors, authors must state that the research was supported by internal funds only. (v) Each table should begin on a separate page, be numbered consecutively (Table 1, Table 2, etc.) and have a caption consistent with others in this journal. (vi) Figure legends should be included with the manuscript beginning on a separate sheet of paper (not printed below the figures). Tables and figures should be so constructed that they, together with their captions and legends, will be intelligible with minimal reference to the text
References: should be assembled beginning on a separate sheet. In the text they should be referred to by name and year (Harvard System). When referring to a work by more than two authors, the name of the first author should be given followed by et al. Examples of the correct format for citation within the text are (Jessor and Jessor, 1977) and (Chutuape et al., 2001). Personal communications and papers submitted for publication should be so indicted and appear with the source or author~{!/~}s name(s) in the text in parentheses. References should be listed alphabetically by first author and must consist of names and initials of all authors, year, title of paper, abbreviated title of journal, volume number and first and last page numbers of the paper. Abbreviations of journal titles should conform to those used by Index Medicus (http://www.nlm.nih.gov/tsd/serials/lji.html). References to journals, books and multi-author books should be in accord with the following examples:
Chutuape, M.A., Katz, E.C., Stitzer, M.L., 2001. Methods for enhancing transition of substance dependent patients from inpatient to outpatient treatment. Drug Alcohol Depend. 61, 137-143.
Jessor, R., Jessor, S.L., 1977. Problem Behaviour and Psychosocial Development: A Longitudinal Study of Youth. Academic Press, New York.
Smith, S.G., Davis, W.M., 1975. A method for chronic intravenous drug administration in the rat. In: Ehrenpreis, S., Neidle, A. (Eds.), Methods in Narcotics Research. Marcel Dekker, New York, pp. 3-21.
Specific instructions for citing information on the Internet can be obtained from the editors. Because information can change, the date of accessing the Internet site must be included.
Illustrations: Should be designed to fit either a single column (8.25 cm) or the full text width (17.5 cm) after reduction. The degree of reduction will determined by the publisher to permit reproduction All line drawings or computer generated graphs should be printed on white paper with a high quality (e.g. Laser) printer. Photographs (one set) should be supplied as clear black-and-white prints on glossy paper. Symbols should be used sparingly and direct labeling with an explicative term or abbreviation is preferred. All symbols and lettering should be large enough to permit reduction. The use of colour photographs is welcomed, however, this will incur a modest charge to the author(s). Illustrations should not include legends, which should be provided beginning on a separate sheet of paper.
Electronic manuscripts: The final form of revised manuscripts should be submitted on a 3.5-inch disk. Separate files for the illustrations are welcomed if available. Please specify the type of computer (IBM PC compatibility preferred) and word processing and graphics packages used. Ensure that the digit "0" and capital letter "O" and the digit "1" and the letters "I" or "l" are not used interchangeably.
Ethics of experimentation: The College on Problems of Drug Dependence is committed to the protection of animal and human research subjects. Studies submitted to Drug and Alcohol Dependence must have been conducted in accordance with the Declaration of Helsinki and/or with the Guide for the Care and use of Laboratory Subjects as adopted and promulgated by the US National Institutes of Health and/or according to requirements of all applicable local and international standards. Studies that entail pain or distress will be assessed in terms of the balance between the distress inflicted and the likelihood of benefit, and must be of such a nature that their objectives could not have been achieved by using less stressful procedures. All authors must attest in the cover letter that all applicable subject protection guidelines and regulations were followed in the conduct of the research. Authors must conform to the highest standards of ethical conduct in the submission of accurate data, acknowledging the work of others, and divulging potential conflicts of interests. Policies on the handling of evidence for scientific misconduct can be obtained from the editors.
Proofs: Authors will receive galley proofs, which they are requested to correct and return within three days of receipt. Only printer's errors may be corrected: no change in, or addition to, the edited manuscript will be allowed at this stage.
Reprints: A total of 50 reprints will be provided to the author(s) free of charge. Additional reprints can be ordered at prices shown on the reprint order form accompanying the proofs
The Farmington Consensus
Preamble
The purpose of this statement is to define the basis for shared identity, commitment and purpose among journals publishing in the field of psychoactive substance use and associated problems. Our aim is to enhance the quality of our endeavours in this multi-disciplinary field. We share common concerns and believe that we do well to join together in their solution. To that end we accede to this document as a statement of our consensus and as basis for future collaboration.
1.Commitment to the peer review process
1.1 We are committed to peer review and would expect research reports and scientific reviews to go through this process. As regards to the extent to which other material will be so reviewed, we see that as a matter for editorial discretion, but policies should be declared.
1.2 Referees should be told that their access to the papers on which they have been requested to comment is in strict confidence. Confidentiality should not be broken by pre-publication statements on the content of the submission. Manuscripts sent to reviewers should be returned to the editor or destroyed.
1.3 Referees should be asked to declare to the editor if they have a conflict of interest in relation to the material which they are invited to review, and if in doubt they should consult the editor. We define ~{!.~}conflict of interest~{!/~} as a situation in which professional, personal or financial considerations could be seen by a fair-minded person as potentially in conflict with independence of judgement. Conflict of interest is not in itself wrong-doing.
1.4 We are committed to enhancing the quality and efficacy of the peer review system that our journals operate. To that end we will, within our own journals, audit the quality of peer review on a continuous basis and where possible provide training to enhance the quality of peer review.
2. Expectations of authors
We put the following expectations to authors:
2.1 Authorship: All listed authors on a paper should have been personally and substantially involved in the work leading to the paper.
2.2 Avoidance of double publication: Authors are expected to ensure that no significant part of the submitted material has been published previously and that it is not concurrently being considered by another journal. An exception to this general position may be made when previous publication has been limited to another language, to local publication in report form, or to publication of a conference abstract. In all such instances, authors should consult the editor. Authors are asked to provide the editor at the time of submission with copies of published or submitted reports that are related to that submission. Editors are encouraged to develop their own policies regarding the implications of electronic publishing.
2.3 Sources of funding for the submitted paper must be declared and will be published.
2.4 Conflicts of interest experienced by authors: Authors should declare to the editor if their relationship with any type of funding source might be fairly construed as exposing them to potential conflict of interest.
2.5 Protection of human and animal rights: Where applicable authors should give an assurance that ethical safeguards have been met.
2.6 Technical preparation of papers: Instructions for authors will be published on the technical preparation of papers with the form of these guidelines at the discretion of individual journals.
3. Formal response to breach of expectations by an author
Working in collaboration with our authors, we have a responsibility to support the expectations of good scientific publishing practice. To that end each journal will have defined policies for response to attempted or actual instances of duplicate publication, plagiarism or scientific fraud.
4. Maintaining editorial independence
4.1 We are committed to independence in the editorial process. To the extent that the owner or another body may influence the editorial process, this should be declared, and in that case sources of support from the alcohol, tobacco, pharmaceutical or other relevant interests should be published in the journal.
4.2 We will publish declarations on sources of support received by a journal, and will maintain openness in regard to connections which a journal or its editorial staff may have established which could reasonably be construed as conflict of interest.
4.3 Funding for journal supplements: When we publish journal supplements, an indication will be given of sources of support for their production.
4.4 Refereeing journal supplements: An editorial note will be published to indicate whether they have been peer reviewed.
4.5 Advertising: Acceptance of advertising will be determined by, or in consultation with, the editor of each journal.
15th July 1997
Farmington, CT, USA
In addition, as a service to authors, a blank and adaptable Permissions Form (PDF) is available here on the Drug and Alcohol Dependence Web site, as well as on request from the editorial office. Authors can use this form in seeking permission to reprint previously published material in their contribution.
Once a manuscript has been accepted for publication and is in production at Elsevier Science, authors can monitor the status of their manuscript. This is available online through Manuscript Status.
The Editors have established a Code of Practice for dealing with ethical issues including cases of suspected fraud and scientific misconduct.
What rights do I retain as author?
As an author, you retain rights for large number of author uses, including use by your employing institute or company. These rights are retained and permitted without the need to obtain specific permission from Elsevier.
Patent and trademark rights or rights to any process or procedure described in the article.
The right to photocopy or make single electronic copies of the article for their own personal use, including for their own classroom use, or for the personal use of colleagues, provided those copies are not offered for sale and are not distributed in a systematic way outside of the employing institution.
The right to post the article on a secure network (not accessible to the public) within the employer's institution.
The right to retain a preprint version of the article on a public electronic server such as the World Wide Web. Elsevier does not require that authors remove from publicly accessible servers versions of their paper that differ from the version as published by Elsevier. See also our information on electronic preprints for a more detailed discussion on these points.
Posting of the article as published on a public server can only be done with Elsevier's specific written permission.
The right, subsequent to publication, to use this article or any part thereof free of charge in a printed compilation of works of their own, such as collected writings or lecture notes.
If the article is a "work for hire" made within the scope of the author's employment, the employer may use all or part of the information in this article for intra-company use.
The right to include the article in a thesis or dissertation provided that this is not to be published commercially.
The right to present the paper at a meeting or conference and to hand copies of the paper to the delegates attending the meeting.
The right to publish a different or extended version of the paper so long as it is sufficiently new to be considered a new work.
The right to expand the article into book-length form for publication.
The right to re-use parts of the paper in other works, provided that the new work is not to be published commercially.
Other uses by authors should be authorized by Elsevier through the Global Rights Department, and authors are encouraged to let Elsevier know of any particular needs or requirements.
Why does Elsevier request transfer of copyright?
Elsevier wants to ensure that it has the exclusive distribution right, for all media. Such a right can be obtained through an exclusive license from authors, but there is virtually no difference between transfer and exclusive license. Given that there is virtually no difference, it seems to us that transfer does give an advantage in the elimination of any ambiguity or uncertainty about Elsevier's ability to distribute or sub-license.
Why does Elsevier believe it needs exclusive rights?
The research community needs certainty with respect to the validity, normally obtained through the peer review process, of scientific papers. The scientific record must be clear and unambiguous. Elsevier believes that by obtaining the exclusive distribution right it will always be clear to researchers that, when they access an Elsevier site to review a paper, they are reading a final version of the paper which has been edited, peer-reviewed, and accepted for publication in an appropriate journal. If Elsevier did not obtain exclusive electronic rights, it is likely that versions of scientific papers would clutter the Internet without clarification of the scientific status of such versions. See also our information on electronic preprints for more detailed discussion on these points.
How do I obtain permission to use material from Elsevier publications?
Requests for permission to reproduce materials from books and journals published by Elsevier BV, Elsevier Science Ltd, Elsevier Science Inc, Elsevier Science SA, Elsevier Science Ireland Ltd and the Pergamon imprint are handled by the Global Rights Department in Oxford.
How do I obtain permission to use material from former Harcourt Health Science publications?
From mid-October 2002, requests to use material from books and journals published by Balliere Tindall, Churchill Livingstone or Mosby and Saunders are handled in our Philadelphia Rights Department. Please send your requests by e-mail to healthpermissions@elsevier.com or by fax to (+1) 215 238 2239.
How do I obtain permission from other publishers?
A letter [ Word document or pdf ] is available to help you prepare your request to another Publisher to reproduce their material in an Elsevier publication.
Where should I send requests for permission that I receive from other authors?
Please forward requests to re-use all or part of your article, or to use figures contained within it, to the Global Rights Department.
Can you provide me with a PDF file of my article?
Unfortunately, for logistical reasons it is not currently Elsevier policy to provide PDF files. If this poses a particular problem for you or if you have a specific requirement, please contact the Global Rights Department.
What is Elsevier policy on using patient photographs?
If you wish to include photographs of patients in an Elsevier publication, you will need to adhere to the following requirements:
In order to comply with data protection and privacy rules, each individual who appears in such a photograph must be made aware prior to photographs being taken of the fact that such photographs are being taken and of all of the purposes for which you wish to use them and must give his/her explicit consent. If such consent is made subject to any conditions (for example, adopting measures to prevent personal identification of the person concerned), Elsevier must be made aware of all such conditions. Particular care should be taken where photographs of children are concerned.
If a photograph features a patient's head or face or if any reference is made to a patient's name or other personal details, then specific written consent from the patient to such use must be provided to Elsevier on request.
Editorial Board
Editor-in-Chief:
R.L. Balster, Virginia Commonwealth University, Medical College of Virginia, Room 754 or 756 Blackwell Smith Building, 410 N 12th Street, P.O. Box 980310, Richmond VA 23298-0310, USA
Co-Editor:
I. Stolerman, Institute of Psychiatry, De Crespigny Park, Denmark Hill, London SE5 8AF, UK
Editorial Board:
F.J. Alvarez, Valladolid, Spain
L. Amass, Los Angeles, CA, USA
J. Anthony, Baltimore, MD, USA
W.K. Bickel, Burlington, VT, USA
K.T. Brady, Charleston, SC, USA
I. Crome, Wolverhampton, UK
T.J. Crowley, Denver, CO, USA
S. Darke, Kensington, NSW, Australia
G. Di Chiara, Cagliari, Italy
C. Drummond, London, UK
M.E. Ensminger, Baltimore, MD, USA
M. Farr~{(&~}, Barcelona, Spain
M. Fischman, New York, NY, USA
B.F. Grant, Rockville, MD, USA
D.K. Hatsukami, Minneapolis, MN, USA
M.Y. Iguchi, Santa Monica, CA, USA
C.-E. Johanson, Detroit, MI, USA
K.M. Johnson, Galveston, TX, USA
M. Kuhar, Atlanta, GA, USA
R.J. Lamb, San Antonio, TX, USA
B.R. Martin, Richmond, VA, USA
N. McKeganey, Glasgow, UK
A.T. McLellan, Philadelphia, PA, USA
H.M. Pettinati, Philadelphia, PA, USA
V.R. Preedy, London, UK
K.L. Preston, Baltimore, MD, USA
P.H. Reuter, College Park, MD, USA
B.J. Rounsaville, New Haven, CT, USA
A.J. Saxon, Seattle, WA, USA
J.L. Sorensen, San Francisco, CA, USA
E.C. Strain, Baltimore, MD, USA
J. Strang, London, UK
D. Svikis, Baltimore, MD, USA
R. Tarter, Pittsburgh, PA, USA
L. Terenius, Stockholm, Sweden
M. Tsuang, Boston, MA, USA
H.-U. Wittchen, Munich, Germany
W.L. Woolverton, Jackson, MS, USA
R. Zucker, Ann Arbor, MI, USA
|
刊名字顺( Alphabetical List of Journals):
返回页首 